Press releases | WebDisclosure

Basculer en Français

11086	Companies
243492	Keywords
171644	Articles
131142	Press releases

Home
Press releases

PRESS RELEASE

published on 09/21/2026 at 17:45, 7 days ago

LUMIBIRD : Résultats du premier semestre 2026, forte croissance et amélioration de la rentabilité de la photonique
Le groupe Lumibird enregistre une forte croissance de +7,4 % de son chiffre d'affaires au premier semestre 2026, notamment grâce à la division Photonique. L'EBITDA de la Photonique progresse de +20,2 % avec une marge à 16,5 %

Croissance Rentabilité EBITDA Photonique LUMIBIRD
PRESS RELEASE

published on 09/21/2026 at 17:45, 7 days ago

LUMIBIRD: 2026 first-half results: photonics strong growth and improved profitability
Lumibird Group reports strong growth in Photonics Division with revenue up 15.3% and EBITDA margin increase. Net income rises by 4.5%. Analysts optimistic about future growth and profitability

Revenue Growth EBITDA Margin Future Prospects Photonics Division LUMIBIRD Group
PRESS RELEASE

published on 09/21/2026 at 17:45, 7 days ago

RÉSULTATS SEMESTRIELS 2026 POSITIFS - INVESTISSEMENTS SOUTENUS POUR ANTICIPER LA CROISSANCE FUTURE
STREAMWIDE annonce des revenus semestriels en progression de 12% et des investissements soutenus. Résultat net en baisse à 0,8 M€ suite à des coûts juridiques aux États-Unis

Résultat Net Streamwide Revenus Semestriels Investissements Soutenus Coûts Juridiques
PRESS RELEASE

published on 09/21/2026 at 17:45, 7 days ago

POSITIVE H1 2026 RESULTS - CONTINUED INVESTMENT TO DRIVE FUTURE GROWTH
STREAMWIDE announces H1 2026 results with revenue growth driven by SaaS projects and international expansion. Strong financial position and focus on recurring revenues

Revenue Growth International Expansion Streamwide H1 2026 Results SaaS Projects
PRESS RELEASE

published on 09/21/2026 at 17:40, 7 days ago

Résultats du 1er semestre 2026 : Forte croissance du chiffre d'affaires, de la rentabilité et du free cash-flow opérationnel. Confirmation des perspectives annuelles.
PRESS RELEASE

published on 09/21/2026 at 17:40, 7 days ago

2026 First Half Results: Strong Growth in Revenue, Profitability and Operating Free Cash Flow Full-year guidance confirmed
Vusion reports strong financial performance in H1 2026 with revenue growth of €820m in IFRS (+34%) and €839m on an adjusted basis (+29%). VAS revenue sees significant increase. EBITDA, EBIT, and net income show substantial growth. Operating free cash flow improves by 51%, ending with a net cash position of €197m. Full-year 2026 guidance confirmed

EBITDA Revenue Growth Financial Performance Cash Flow Vusion
PRESS RELEASE

published on 09/21/2026 at 17:37, 7 days ago

Greenland Mines (NASDAQ: GRML) Highlights Critical Minerals Role Following U.S.-Denmark-Greenland Security Agreement
Austin, Texas, United States, September 21st, 2026, FinanceWire
PRESS RELEASE

published on 09/21/2026 at 17:37, 7 days ago

Greenland Mines (NASDAQ: GRML) Highlights Critical Minerals Role Following U.S.-Denmark-Greenland Security Agreement
Austin, Texas, September 21st, 2026, FinanceWire
PRESS RELEASE

published on 09/21/2026 at 17:27, 7 days ago

UnCruise Adventures Named to Best Adventure Tour Company List for Third Year in Newsweek’s 2026 Readers’ Choice™ Awards
JUNEAU, AK, September 21st, 2026, FinanceWire
PRESS RELEASE

published on 09/21/2026 at 17:00, 7 days 1 hour ago

Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Menarini Group and NewAmsterdam Pharma receive European Commission approval for Ubeslo and Evlarco, marking a milestone for cardiovascular disease treatment with LDL-C reduction therapies

European Commission Approval Menarini Group NewAmsterdam Pharma Ubeslo Evlarco

Accesswire

Published on 09/28/2026 at 15:00, 3 hours 3 minutes ago

Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Published on 09/28/2026 at 14:45, 3 hours 18 minutes ago

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Published on 09/28/2026 at 14:30, 3 hours 33 minutes ago

Drilling at Cat Creek Intersects a Copper-Molybdenum Porphyry System Visible Molybdenite-Chalcopyrite Over Significant Core Widths
Published on 09/28/2026 at 14:30, 3 hours 33 minutes ago

Predictiv AI Completes United Nations Fleet Management Deployment Following Competitive Procurement Win
Published on 09/28/2026 at 14:00, 4 hours 3 minutes ago

DoJ and DoW move to Support Resumption of Operations at Colosseum

View all ACCESSWIRE

EQS Group

Published on 09/28/2026 at 17:53, 10 minutes ago

EQS-Adhoc: MeVis Medical Solutions AG: Forecast Adjustment for Fiscal Year 2025/2026
Published on 09/28/2026 at 17:49, 13 minutes ago

XTPL increased its global project pipeline in H1 2026, building more sales opportunities for subsequent periods
Published on 09/28/2026 at 17:45, 17 minutes ago

EQS-Adhoc: Airbus SE: Airbus reports share buyback transactions 21-25 September 2026
Published on 09/28/2026 at 17:40, 23 minutes ago

LIGHTON: Information relative au nombre total de droits de vote et d'actions composant le capital social au 31 août 2026.
Published on 09/28/2026 at 17:40, 23 minutes ago

LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 31 august 2026.

Les Echos

Published on 09/28/2026 at 17:54, 8 minutes ago

Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 8 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 18 minutes ago

Weekly share buyback
Published on 09/28/2026 at 17:45, 18 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 09/28/2026 at 17:35, 28 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026

View all LES ECHOS COMFI WIRE